JP2016509994A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016509994A5 JP2016509994A5 JP2015557219A JP2015557219A JP2016509994A5 JP 2016509994 A5 JP2016509994 A5 JP 2016509994A5 JP 2015557219 A JP2015557219 A JP 2015557219A JP 2015557219 A JP2015557219 A JP 2015557219A JP 2016509994 A5 JP2016509994 A5 JP 2016509994A5
- Authority
- JP
- Japan
- Prior art keywords
- kit
- diet
- low protein
- calories
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000020905 low-protein-diet Nutrition 0.000 claims 20
- 235000018102 proteins Nutrition 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 235000019197 fats Nutrition 0.000 claims 8
- 241000196324 Embryophyta Species 0.000 claims 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- 229930182817 methionine Natural products 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 2
- 239000004473 Threonine Substances 0.000 claims 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 235000021236 calorie-restricted diet Nutrition 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 235000005911 diet Nutrition 0.000 claims 2
- 230000037213 diet Effects 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 235000020805 dietary restrictions Nutrition 0.000 claims 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- 235000021084 monounsaturated fats Nutrition 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- 235000021085 polyunsaturated fats Nutrition 0.000 claims 2
- 235000021003 saturated fats Nutrition 0.000 claims 2
- 239000013589 supplement Substances 0.000 claims 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 2
- 239000008158 vegetable oil Substances 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- 239000005639 Lauric acid Substances 0.000 claims 1
- 235000021360 Myristic acid Nutrition 0.000 claims 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 1
- 108010064851 Plant Proteins Proteins 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 231100000196 chemotoxic Toxicity 0.000 claims 1
- 230000002604 chemotoxic effect Effects 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 239000003240 coconut oil Substances 0.000 claims 1
- 235000019864 coconut oil Nutrition 0.000 claims 1
- 229960004397 cyclophosphamide Drugs 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 239000003797 essential amino acid Substances 0.000 claims 1
- 235000020776 essential amino acid Nutrition 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 235000020845 low-calorie diet Nutrition 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 239000004006 olive oil Substances 0.000 claims 1
- 235000008390 olive oil Nutrition 0.000 claims 1
- 235000021118 plant-derived protein Nutrition 0.000 claims 1
- 235000003441 saturated fatty acids Nutrition 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 235000021391 short chain fatty acids Nutrition 0.000 claims 1
- 150000004666 short chain fatty acids Chemical class 0.000 claims 1
- 239000003549 soybean oil Substances 0.000 claims 1
- 235000012424 soybean oil Nutrition 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 235000021076 total caloric intake Nutrition 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361763797P | 2013-02-12 | 2013-02-12 | |
| US61/763,797 | 2013-02-12 | ||
| PCT/US2014/016025 WO2014127000A2 (en) | 2013-02-12 | 2014-02-12 | Methods and diets to protect against chemotoxicity and age related illnesses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019179570A Division JP2020073473A (ja) | 2013-02-12 | 2019-09-30 | 化学毒性および年齢関連性の病気から保護するための方法および食事制限 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016509994A JP2016509994A (ja) | 2016-04-04 |
| JP2016509994A5 true JP2016509994A5 (enExample) | 2017-03-09 |
| JP6885671B2 JP6885671B2 (ja) | 2021-06-16 |
Family
ID=51297596
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015557219A Active JP6885671B2 (ja) | 2013-02-12 | 2014-02-12 | 化学毒性および年齢関連性の病気から保護するための方法および食事制限 |
| JP2019179570A Pending JP2020073473A (ja) | 2013-02-12 | 2019-09-30 | 化学毒性および年齢関連性の病気から保護するための方法および食事制限 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019179570A Pending JP2020073473A (ja) | 2013-02-12 | 2019-09-30 | 化学毒性および年齢関連性の病気から保護するための方法および食事制限 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9237761B2 (enExample) |
| EP (2) | EP3510875B1 (enExample) |
| JP (2) | JP6885671B2 (enExample) |
| KR (1) | KR20150124962A (enExample) |
| CN (3) | CN109187991B (enExample) |
| AU (3) | AU2014216349B2 (enExample) |
| BR (1) | BR112015019223A2 (enExample) |
| CA (1) | CA2900782C (enExample) |
| ES (1) | ES2807781T3 (enExample) |
| MX (1) | MX382484B (enExample) |
| RU (2) | RU2674681C2 (enExample) |
| WO (1) | WO2014127000A2 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2909802B1 (en) * | 2012-10-22 | 2020-08-12 | University of Southern California | Diet formulations promoting tissue/organ regeneration |
| ES2807781T3 (es) * | 2013-02-12 | 2021-02-24 | Univ Southern California | Composición de dieta para usar en un método terapéutico para reducir los niveles de glucosa en sangre y/o de IGF-1 |
| CN114052245A (zh) * | 2013-07-01 | 2022-02-18 | 南加利福尼亚大学 | 膳食包装 |
| US10172839B2 (en) | 2014-03-06 | 2019-01-08 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
| CA2944479C (en) | 2014-04-02 | 2023-02-21 | University Of Southern California | Dietary formulation and method for treating autoimmune and inflammatory diseases |
| KR20180016333A (ko) | 2015-02-12 | 2018-02-14 | 유니버시티 오브 써던 캘리포니아 | 질환 예방 및 치료에서의 성장 호르몬 수용체의 차단제 |
| CA3108664A1 (en) * | 2015-04-16 | 2016-10-20 | University Of Southern California | Fasting mimicking diet (fmd) and glucose lowering drugs protect normal cells and generate cancer sensitizing conditions in response to standard and high glucose conditions induced by rapamycin and dexamethasone |
| RU2724525C2 (ru) * | 2015-05-06 | 2020-06-23 | Юниверсити Оф Саутерн Калифорния | Способ лечения повышенных уровней инсулина или глюкозы с использованием гипокалорийного или бескалорийного рациона или рациона, имитирующего воздержание от пищи |
| WO2017097865A1 (en) * | 2015-12-07 | 2017-06-15 | Istituto Europeo Di Oncologia | Combination of caloric restriction (cr) or igf1/insulin receptor inhibitor with lsd1 inhibitor |
| CN108463121A (zh) * | 2016-01-12 | 2018-08-28 | 南加利福尼亚大学 | 长期禁食模仿作为多发性骨髓瘤和其它癌症的膳食治疗的用途 |
| MX2018009849A (es) | 2016-02-15 | 2018-11-09 | Univ Southern California | Combinaciones de farmacos y metodos para estimular regeneracion de tipo embrionaria para tratar diabetes y otras enfermedades. |
| AU2017261723B2 (en) * | 2016-05-11 | 2023-02-09 | University Of Southern California | Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases. |
| IT201700008499A1 (it) * | 2017-01-26 | 2018-07-26 | Univ Degli Studi Genova | Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio |
| US11284640B2 (en) * | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
| US11504408B2 (en) * | 2018-03-15 | 2022-11-22 | University Of Southern California | Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology |
| ES2992080T3 (es) * | 2018-06-07 | 2024-12-09 | Nestle Sa | Métodos y composiciones para incrementar los cuerpos cetónicos en animales |
| WO2020015842A1 (en) | 2018-07-18 | 2020-01-23 | Michalsen Andreas | Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer |
| JP2020059699A (ja) * | 2018-10-04 | 2020-04-16 | 株式会社明治 | 難治性癌の食事療法およびそれに適した治療食 |
| CN113301807A (zh) | 2018-11-09 | 2021-08-24 | L·纽乐股份有限公司 | 间歇性禁食模仿的营养棒 |
| EP3963599A4 (en) * | 2019-04-30 | 2023-01-18 | University of Southern California | FASTING DIET AS AN INTERVENTION IN ALZHEIMER'S DISEASE |
| IT201900009954A1 (it) * | 2019-06-24 | 2020-12-24 | Fondazione Irccs Istituto Naz Dei Tumori | Preparazione alimentare a basso contenuto calorico per l’alimentazione di pazienti affetti da neoplasie |
| CN112273641A (zh) * | 2019-07-23 | 2021-01-29 | 中国科学院上海营养与健康研究所 | 一种非节食性的高低蛋白食物交替使用有效干预糖尿病的方法 |
| WO2021126968A1 (en) * | 2019-12-16 | 2021-06-24 | University Of Southern California | Utilization of a fasting-mimicking diet to reduce senescent cells and inflammation |
| EP4076458A1 (en) * | 2019-12-19 | 2022-10-26 | Leibniz-lnstitut Für Altersforschung | Nad-precursors and dietary restriction for treating age-related medical conditions |
| IT202000008740A1 (it) | 2020-04-23 | 2021-10-23 | L Nutra Inc | Composizione dietetica per l’incremento della massa magra e della massa muscolare |
| US12029231B2 (en) * | 2020-07-13 | 2024-07-09 | L-Nutra Inc. | Method for the treatment of depression |
| IT202000016957A1 (it) | 2020-07-13 | 2022-01-13 | Univ Degli Studi Di Palermo | Composizione dietetica per il trattamento della depressione |
| EP4190173B1 (en) * | 2020-09-23 | 2024-07-17 | Aminovita S.L. | Metabolic cancer therapy |
| TW202227113A (zh) | 2020-12-01 | 2022-07-16 | 南加州州立大學 | 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活 |
| CN114631629A (zh) * | 2020-12-15 | 2022-06-17 | 中国科学院上海营养与健康研究所 | 一种低蛋白治疗肥胖的方法 |
| CN114631628A (zh) * | 2020-12-15 | 2022-06-17 | 中国科学院上海营养与健康研究所 | 一种增加血液fgf21浓度的方法 |
| CN114794487A (zh) * | 2021-01-22 | 2022-07-29 | 中国科学院上海营养与健康研究所 | 一种治疗糖尿病的方法 |
| WO2024044036A1 (en) * | 2022-08-23 | 2024-02-29 | University Of Southern California | Dietary compositions to extend longevity while maximizing strength and function |
| US20250194656A1 (en) * | 2023-12-14 | 2025-06-19 | L-Nutra Inc. | Longevity extending consumable products for maximizing strength and function, methods of consumption and manufacture |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406853B1 (en) * | 1999-12-23 | 2002-06-18 | The Regents Of The University Of California | Interventions to mimic the effects of calorie restriction |
| WO2002103031A2 (en) * | 2001-06-15 | 2002-12-27 | Interleukin Genetics, Inc. | Methods for detecting and treating the early onset of aging-related conditions |
| US20040081678A1 (en) * | 2002-08-09 | 2004-04-29 | Anthony Cincotta | Therapeutic process for the treatment of obesity and associated metabolic disorders |
| US20050031671A1 (en) * | 2003-08-06 | 2005-02-10 | James Johnson | Weight management, longevity and health paradigm |
| BRPI0519507A2 (pt) * | 2004-12-27 | 2009-03-10 | Nestec Sa | uso de fàrmula lactente com teor de proteÍna reduzido |
| CN101378771B (zh) * | 2006-02-01 | 2012-11-21 | 雀巢技术公司 | 用于延长寿命的营养系统和方法 |
| ES2800327T3 (es) * | 2008-04-24 | 2020-12-29 | Univ Of Southern California Usc Stevens | Composiciones dietéticas y métodos de protección contra la quimioterapia o radioterapia |
| CN101385543A (zh) * | 2008-10-23 | 2009-03-18 | 上海交通大学 | 低蛋白食品及其制备方法 |
| PL2490684T3 (pl) * | 2009-10-22 | 2018-07-31 | University Of Southern California | Sposoby i formulacje odżywcze dla zwiększenia skuteczności i zmniejszenia skutków ubocznych leczenia nowotworu |
| EP2909802B1 (en) * | 2012-10-22 | 2020-08-12 | University of Southern California | Diet formulations promoting tissue/organ regeneration |
| ES2807781T3 (es) * | 2013-02-12 | 2021-02-24 | Univ Southern California | Composición de dieta para usar en un método terapéutico para reducir los niveles de glucosa en sangre y/o de IGF-1 |
-
2014
- 2014-02-12 ES ES19160815T patent/ES2807781T3/es active Active
- 2014-02-12 CN CN201811023405.1A patent/CN109187991B/zh active Active
- 2014-02-12 KR KR1020157024630A patent/KR20150124962A/ko not_active Ceased
- 2014-02-12 CN CN202111523134.8A patent/CN114236130A/zh active Pending
- 2014-02-12 CN CN201480008545.5A patent/CN105008929B/zh active Active
- 2014-02-12 BR BR112015019223A patent/BR112015019223A2/pt not_active Application Discontinuation
- 2014-02-12 EP EP19160815.7A patent/EP3510875B1/en active Active
- 2014-02-12 US US14/178,953 patent/US9237761B2/en active Active
- 2014-02-12 JP JP2015557219A patent/JP6885671B2/ja active Active
- 2014-02-12 RU RU2015134780A patent/RU2674681C2/ru active
- 2014-02-12 WO PCT/US2014/016025 patent/WO2014127000A2/en not_active Ceased
- 2014-02-12 CA CA2900782A patent/CA2900782C/en active Active
- 2014-02-12 AU AU2014216349A patent/AU2014216349B2/en active Active
- 2014-02-12 EP EP14751117.4A patent/EP2956776A4/en not_active Ceased
- 2014-02-12 MX MX2015010320A patent/MX382484B/es unknown
- 2014-02-12 RU RU2018141475A patent/RU2018141475A/ru unknown
-
2016
- 2016-01-15 US US14/996,946 patent/US20160331016A1/en not_active Abandoned
- 2016-10-20 US US15/298,963 patent/US20170035094A1/en not_active Abandoned
-
2019
- 2019-09-30 JP JP2019179570A patent/JP2020073473A/ja active Pending
-
2020
- 2020-01-15 AU AU2020200297A patent/AU2020200297B2/en active Active
-
2022
- 2022-04-27 AU AU2022202764A patent/AU2022202764A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016509994A5 (enExample) | ||
| RU2015134780A (ru) | Способы и рационы для защиты от химической интоксикации и связанных с возрастом заболеваний | |
| RU2012115658A (ru) | Стабилизация пробиотика | |
| JP2016505804A5 (enExample) | ||
| JP2024149504A (ja) | 断続的断食模倣のための栄養バー | |
| JP2018012722A5 (enExample) | ||
| RU2011120780A (ru) | Питательная композиция, способствующая здоровому развитию и росту | |
| ES2196983B1 (es) | Polvo nutriente para una formula infantil con aminoacidos libres y nucleotidos. | |
| CA3165947A1 (en) | Sleep dietary supplement | |
| JP2015510888A5 (enExample) | ||
| RU2012139658A (ru) | Композиции и способы для доставки питательных веществ | |
| BR112015032572A2 (pt) | composições e métodos para melhorar o desempenho durante exercícios | |
| RU2011144102A (ru) | Снижение риска ожирения | |
| ATE442050T1 (de) | Nahrungsergänzungsmittel oder functional food enthaltend íl-kombination | |
| JP2017093454A (ja) | 食品マトリックス中の反応性アミノ酸の安定性のための組成物及び方法 | |
| RU2009126763A (ru) | Лечение общих расстройств развития | |
| AU2007204347B2 (en) | Treatment of stressed patients | |
| CN1717184A (zh) | 用于提供谷氨酰胺的方法和组合物 | |
| BR112014003445A2 (pt) | métodos para melhora de sintomas ou condições causadas por estresse | |
| Ochiai et al. | Effect of a fermented brown rice extract on the gastrointestinal function in methotrexate-treated rats | |
| CA3166314A1 (en) | Dietary supplement composition comprising collagen | |
| Castro et al. | Dietary carbohydrates and lipid source affect oxidative status of European sea bass (Dicentrarchus labrax) juveniles | |
| ES2596456B1 (es) | Preparado de carne picada | |
| Korkmaz | Are Vitamin D Drops Containing 400 IU Daily Adequate for Preventing Vitamin D Deficiency? | |
| BR102016030528A2 (pt) | composição nutricional hipoalergênica à base de arroz hidrolisado ou extensamente hidrolisado, seu uso e produto alimentício |